SLDB
Solid Biosciences Inc.
Key Financials
Operating Income
$-179206000
↓ 38.1%
Net Income
$-117223000
↓ 56.7%
EPS (Diluted)
$-1.99
↑ 35.0%
Revenue
$8.1M
↓ 40.6%
Total Assets
$232.5M
↑ 23.3%
Total Liabilities
$52.5M
↑ 2.2%
Shareholders' Equity
$180.0M
↑ 31.2%
Cash & Equivalents
$59.9M
↓ 25.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| PRE 14A | 4/10/2026 | View on SEC |
| 8-K | 4/10/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
| EFFECT | 3/31/2026 | View on SEC |
| EFFECT | 3/31/2026 | View on SEC |
| S-3 | 3/19/2026 | View on SEC |
| S-3 | 3/19/2026 | View on SEC |
| S-8 | 3/19/2026 | View on SEC |
| 10-K | 3/19/2026 | View on SEC |
| SCHEDULE 13D/A | 3/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SLDB |
| Company Name | Solid Biosciences Inc. |
| CIK | 1707502 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-337-4680 |